StonvexLoading…
StonvexStonvexStonvexCore line items from QSR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $9.43B | $8.41B | $7.02B | $6.50B |
Operating Income | $2.20B | $2.42B | $2.05B | $1.90B |
Net Income | $1.07B | $1.45B | $1.72B | $1.48B |
EPS (Diluted) | $2.35 | $3.18 | $3.76 | $3.25 |
Total Assets | $25.61B | $24.63B | $23.39B | $22.75B |
Total Liabilities | $20.46B | $19.79B | $18.66B | $18.48B |
Cash & Equivalents | $1.16B | $1.33B | $1.14B | $1.18B |
Free Cash Flow OCF − CapEx | $1.45B | $1.30B | $1.20B | $1.39B |
Shares Outstanding | 346.32M | 324.43M | 312.45M | 307.14M |